PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses

Shaun Purcell, Benjamin M. Neale, Katherine EO Todd-Brown, +8

The American Journal of Human Genetics

Genome-wide Association StudyWhole-genome AssociationLinkage DisequilibriumGenotype-phenotype AssociationPopulation-based Linkage Analyses +10

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, +6

International Journal of Cancer

Mortality WorldwideCancer ManagementEpidemiology Of CancerPathologyCancer Incidence +15

Comprehensive molecular portraits of human breast tumours

Nature

Breast OncologyComprehensive Molecular PortraitsTumor HeterogeneityPathologyBreast Cancer +4

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

Simon Forbes, David Beare, Prasad Gunasekaran, +14

Nucleic Acids Research

ESEfinder: a web resource to identify exonic splicing enhancers

Luca Cartegni

Nucleic Acids Research

Sequence MotifExon SkippingRna ProcessingFunctional GenomicsPoint Mutations +10

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

Hiroshi Tanaka, Hirofumi Arakawa, Tatsuya Yamaguchi, +5

Nature

Genome InstabilityDna DamageP53-dependent Cell-cycle CheckpointRibonucleotide Reductase GeneNatural Sciences +7

The genetic attributable risk of breast and ovarian cancer

Elizabeth B. Claus, Joellen M. Schildkraut, W. Douglas Thompson, +1

Cancer

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

Antonis C. Antoniou, Paul D.P. Pharoah, Greg McMullan, +5

British Journal of Cancer

Breast OncologyOncologyMedicineGeneticsComprehensive Model +9

Contributions of ATM mutations to familial breast and ovarian cancer.

Yvonne R. Thorstenson, Adriane Roxas, Regina Kroiss, +9

PubMed

Atm MutationsSomatic VariantCancer PathologyBreast OncologyMedicine +8

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals

Kirsi M. Kuusisto, Aleksandra Bebel, Mauno Vihinen, +2

Breast Cancer Research